Pular para o conteúdo
Pallister-Hall syndrome
ORPHA:672CID-10 · Q87.8CID-11 · LD2F.1YOMIM 146510DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
neuroInício neonatalHerança AD/Unknown
Também conhecida comoSPH
Sinônimos clínicos: Síndrome de hamartoblastoma hipotalâmico

A Síndrome de Pallister-Hall (SPH) é uma doença genética de herança dominante que causa múltiplas malformações. Ela se caracteriza por um nódulo benigno no hipotálamo (uma parte do cérebro), problemas no funcionamento da hipófise (uma glândula também no cérebro), epiglote dividida (uma estrutura da garganta), dedos a mais nas mãos ou nos pés e, mais raramente, problemas nos rins e malformações nos órgãos genitais e urinários.

Última verificação: Fonte: sem afirmação sobre o SUS a verificarEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A síndrome de Pallister-Hall é um distúrbio que afeta o desenvolvimento de muitas partes do corpo. A maioria das pessoas com essa condição tem dedos extras nas mãos e/ou nos pés (polidactilia), e a pele entre alguns dedos das mãos ou dos pés pode estar fundida (sindactilia cutânea). Um crescimento anormal no cérebro chamado hamartoma hipotalâmico é característico desse distúrbio. Em muitos casos, esses crescimentos não causam nenhum problema de saúde; porém, alguns hamartomas hipotalâmicos provocam convulsões ou anomalias hormonais que podem ser ameaçadoras à vida na infância. Outras características da síndrome de Pallister-Hall incluem uma malformação das vias aéreas chamada epiglote bifida, uma obstrução da abertura anal (ânus imperfurado) e anomalias renais. Embora os sinais e sintomas desse distúrbio variem de leves a graves, apenas uma pequena porcentagem de pessoas com a condição apresenta complicações sérias.

Fonte: MedlinePlus Genetics (NLM/NIH), traduzido
📋
Informacoes curadas por IA — podem conter imprecisoes

A Síndrome de Pallister-Hall (SPH) é uma doença genética de herança dominante que causa múltiplas malformações. Ela se caracteriza por um nódulo benigno no hipotálamo (uma parte do cérebro), problemas no funcionamento da hipófise (uma glândula também no cérebro), epiglote dividida (uma estrutura da garganta), dedos a mais nas mãos ou nos pés e, mais raramente, problemas nos rins e malformações nos órgãos genitais e urinários.

Publicações científicas
180 artigos
Último publicado: 2025 Dec

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
100
pacientes catalogados
Início
Antenatal
+ infancy, neonatal
🏥
SUS: Cobertura mínimaScore: 15%
5 procedimentos SIGTAPCID-10: Q87.8
🇧🇷Dados SUS / DATASUS
EXAMES E PROCEDIMENTOS RELACIONADOS (5)
•
Cariótipo — bandas G, Q ou R
•
Pesquisa de microdeleções/microduplicações por FISH
•
Sequenciamento completo do exoma (WES)
•
Dosagem de alfa-fetoproteína
•
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
31 sintomas
😀
Face
13 sintomas
📏
Crescimento
12 sintomas
🧠
Neurológico
10 sintomas
🫘
Rins
10 sintomas
❤️
Coração
6 sintomas

+ 52 sintomas em outras categorias

Características mais comuns

100%prev.
HP:0003577
Frequência: 20/20
100%prev.
Hamartoma hipotalâmico
Frequência: 11/11
92%prev.
Encurtamento de todas as falanges distais dos dedos
Frequência: 12/13
85%prev.
Polidactilia pós-axial
Frequência: 17/20
82%prev.
Metacarpos em forma de Y
Frequência: 14/17
82%prev.
Metatarsos em forma de Y
Frequência: 14/17
147sintomas
Muito frequente (6)
Frequente (39)
Ocasional (45)
Muito raro (24)
Sem dados (33)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 147 características clínicas mais associadas, ordenadas por frequência.

Frequência: 20/20100%
Hamartoma hipotalâmicoHypothalamic hamartoma
Frequência: 11/11100%
Encurtamento de todas as falanges distais dos dedosShortening of all distal phalanges of the fingers
Frequência: 12/1392%
Polidactilia pós-axialPostaxial polydactyly
Frequência: 17/2085%
Metacarpos em forma de YY-shaped metacarpals
Frequência: 14/1782%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico180PubMed
Últimos 10 anos68publicações
Pico20168 papers
Linha do tempo
2025Hoje · 2026🧪 1994Primeiro ensaio clínico📈 2016Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Not applicable.

Curadoria gene-doença

fontes oficiais
GLI3
GLI3Transcriptional activator GLI3Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
GLI3 is processed to GLI3R by the proteasomeHedgehog 'off' state
MECANISMO DE DOENÇA

Greig cephalo-poly-syndactyly syndrome

Autosomal dominant disorder affecting limb and craniofacial development. It is characterized by pre- and postaxial polydactyly, syndactyly of fingers and toes, macrocephaly and hypertelorism.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
27.0 TPM
Cólon sigmoide
21.9 TPM
Fallopian Tube
19.5 TPM
Ovário
19.4 TPM
Cervix Ectocervix
15.9 TPM
OUTRAS DOENÇAS (8)
Pallister-Hall syndromepolysyndactyly 4polydactyly, postaxial, type A1Greig cephalopolysyndactyly syndrome
HGNC:4319UniProt:P10071
SMOProtein smoothenedDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Hedgehog 'off' state
EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
62.8 TPM
Ovário
60.7 TPM
Cervix Ectocervix
56.8 TPM
Útero
50.1 TPM
Pituitária
38.7 TPM
OUTRAS DOENÇAS (5)
congenital hypothalamic hamartoma syndromebasal cell carcinoma, susceptibility to, 1Curry-Jones syndromemeningioma
HGNC:11119UniProt:Q99835

Variantes genéticas (ClinVar)

433 variantes patogênicas registradas no ClinVar.

🧬 GLI3: NM_000168.6(GLI3):c.4099del (p.Ala1367fs) ()
🧬 GLI3: NM_000168.6(GLI3):c.4610del (p.Arg1537fs) ()
🧬 GLI3: NM_000168.6(GLI3):c.2974del (p.Leu992fs) ()
🧬 GLI3: NM_000168.6(GLI3):c.3422_3446del (p.Gln1141fs) ()
🧬 GLI3: NM_000168.6(GLI3):c.1813-6T>A ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 951 variantes classificadas pelo ClinVar.

380
571
VUS (40.0%)
Benigna (60.0%)
VARIANTES MAIS SIGNIFICATIVAS
GLI3: NM_000168.6(GLI3):c.3164G>A (p.Gly1055Asp) [Uncertain significance]
GLI3: NM_000168.6(GLI3):c.3638A>C (p.Tyr1213Ser) [Uncertain significance]
GLI3: NM_000168.6(GLI3):c.3154C>A (p.Pro1052Thr) [Uncertain significance]
GLI3: NM_000168.6(GLI3):c.4186G>A (p.Ala1396Thr) [Uncertain significance]
GLI3: NM_000168.6(GLI3):c.640T>A (p.Ser214Thr) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Pallister-Hall syndrome

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Nenhum país com ensaio aberto no momento.

Pesquisa e ensaios clínicos

1 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
63 papers (10 anos)
#1

Complete loss of IFT27 function leads to a phenotypic spectrum of fetal lethal ciliopathy associated with altered ciliogenesis.

European journal of human genetics : EJHG2025 Mar

Ciliopathies are rare genetic diseases marked by considerable phenotypic heterogeneity and overlap. Among the key mechanisms of cilium biology, its compartmentalization is achieved through gating complexes and active transport such as intraflagellar transport (IFT). Among the IFT components, IFT27 plays a role in BBSome-mediated transport of ciliary membrane proteins required for ciliary signaling. While this gene was first linked to Bardet-Biedl syndrome, we next expanded its phenotypic spectrum to a fetal lethal ciliopathy. Here, we identified a second fetal case with short ribs, polydactyly, hypodysplastic kidneys, imperforate anus, and situs inversus. Genome sequencing identified novel biallelic variants in IFT27. Functional analysis of tissues from both fetal cases revealed that all the identified variants lead to mRNA decay. Immunohistochemistry on fetal kidney sections showed that those variants are associated with altered ciliogenesis. Overall, we showed that complete loss of IFT27 function leads to a severe phenotypic spectrum overlapping with short ribs polydactyly and Pallister-Hall syndromes. In addition, our results argue for a role of IFT27 in ciliogenesis in humans.

#2

C-Terminal End of Gli3 Is Critical for Functional Protein Synthesis and Gli3-Dependent Anatomical Development.

Development, growth &amp; differentiation2025 Dec

The GLI3 gene, a pivotal component of the hedgehog (HH) signaling pathway, plays a fundamental role in the development and patterning of various body structures, including the brain and limbs. Mutations in the GLI3 gene, particularly in the C-terminal domain, are implicated in congenital anomalies such as Greig cephalopolysyndactyly syndrome and Pallister-Hall syndrome. Recent studies have also suggested an archaic human-type mutation in the C-terminal end, which altered downstream gene regulations and anatomical structures in mice. However, the biological effects of the disruption in the Gli3 C-terminal end have not been studied well. Here we report novel Gli3 mutant mice with nonsense mutations in the C-terminal end using CRISPR/Cas12a-mediated genome editing. Analysis of the genotype-phenotype correlations has revealed that the C-terminal end of Gli3 is critical for functional protein synthesis; therefore, the disruption of this region causes severe abnormalities in brain and digit formation. These results provide insight into the mechanisms by which GLI3 mutants can cause adverse consequences during human development or result in diverse phenotypes during evolution.

#3

The molecular characterization of seven novel GLI family zinc finger 3 (GLI3) variants in Chinese families with limb malformations.

Frontiers in genetics2025

GLI family zinc finger 3 (GLI3) is a transcription factor involved in limb development. GLI3 gene variants have been shown to be associated with several human congenital limb malformations, including Greig cephalopolysyndactyly, Pallister-Hall syndrome, non-syndromic postaxial polydactyly (PAP-A/B), and preaxial polydactyly type IV (PPD-IV). The aim of this study was to identify GLI3 gene variants in ten Chinese families with limb malformations. Ten Chinese families with limb malformations were recruited. Variant screening in probands was then performed using NGS, with candidate pathogenic variants verified by polymerase chain reaction (PCR) combined with Sanger DNA sequencing. Variant pathogenicity was evaluated using bioinformatics, evolutionary conservation, and disease and mutant allele co-segregation approaches. The biological effects of missense variants were predicted by three-dimensional protein conformation analysis. Ten GLI3 variants were identified: two missense variants c.1063G>A (p.Val355Ile) and c.1489C>A (p.Leu497Ile), four nonsense variants c.2374C>T (p.Arg792*), c.2008C>T (p.Gln670*), c.1096 C>T (p.Arg366*), and c.2029C>T (p.Gln677*); three frameshift variants c.600delC (p.Tyr200*), c.1880_1881del (p.His627Argfs*48), and c.811_812delCT (p.Leu271Serfs*5); a large fragment deletion of NC_000007.14: g.42061081_42069739. Seven of these ten variants have never been recorded in the Human Gene Variant Database. Ten GLI3 variants were successfully identified in families with different limb malformations, indicating significant clinical and allelic heterogeneity of GLI3-related limb malformations. The present study expands the spectra of pathogenic variants and clinical manifestation for GLI3-related morphological disorder and provides solid evidence for genetic counseling and prenatal gene diagnosis in the affected families.

#4

New Pathogenic Variant in the GLI3 Gene in the First Colombian Patient Associated With Pallister-Hall Syndrome: A Clinical Report.

Molecular genetics &amp; genomic medicine2025 Oct

Pallister-Hall syndrome (PHS) is an extremely rare genetic disorder. It presents as a polymalformative syndrome affecting craniofacial structures, the central nervous system, limbs, various internal organs, and the endocrine system. It is considered a ciliopathy, as it is associated with loss-of-function variants in the GLI3 gene, a transcription factor essential for primary cilium signaling. The syndrome shows marked clinical heterogeneity depending on the type of genetic variant, which makes diagnosis challenging. It is usually suspected at an early age when a hypothalamic hamartoma is associated with polydactyly. Endocrine manifestations are often linked to the hamartoma, further complicating diagnosis. A 23-year-old Colombian patient presented with a history of hypothalamic hamartoma, gelastic seizures, postaxial polydactyly of hands and feet, and craniofacial dysmorphisms. Physical examination revealed dolichocephaly, bilateral epicanthus, broad nasal bridge, short and broad neck, mild cervical kyphosis, mild scoliosis, micrognathia, bilateral ulnar deviation of the fourth and fifth fingers, and overlapping toes on both feet. No genital anomalies were found. Neuropsychological evaluation reported a borderline intellectual quotient of 78. Whole-exome sequencing identified a de novo heterozygous pathogenic variant in GLI3 (c.2151del; p.(Gln71HisfsTer16)), confirmed by Sanger sequencing. We report the first case described in Colombia of a previously unreported truncating genetic variant. We performed a clinical-molecular correlation in a 23-year-old adult whose diagnosis of PHS was delayed until adulthood, years after the initial identification of a hypothalamic hamartoma, refractory gelastic seizures, polydactyly, and mild cognitive impairment. This case broadens the clinical spectrum regarding the viability of patients with PHS into adulthood, showing that it is not restricted to the severe neonatal or infantile presentations classically described.

#5

Two Nonsense GLI3 Variants Are Identified in Two Chinese Families With Polydactyly.

Molecular genetics &amp; genomic medicine2025 Mar

Polydactyly is a prevalent limb deformity with an autosomal dominant inheritance pattern, manifesting in both syndromic and nonsyndromic forms. It exhibits significant etiological and clinical diversity. This study aims to identify the pathogenic cause in two patients with sub-PHS (sub-Pallister-Hall Syndrome) and PAP (postaxial polydactyly), respectively, from two Chinese pedigrees. Exome sequencing was performed on patients to screen for potential pathogenic variants. Subsequently, these variants were validated by Sanger sequencing. The c.3342dupC and c.4431dupT mutant plasmids were transfected into HEK293T cells, and the effects of GLI3 mutations on transcription and protein levels were analyzed via qRT-PCR and Western blot. Additionally, Swiss Model was utilized to predict the effects of mutations on protein tertiary structure. The mutations of GLI3 (NM_000168.6: c.3342dupC; p. A1115Rfs*14) (NM_000168.6: c.4431dupT; p. Glu1478Ter) were identified in affected individuals. These mutations were present exclusively in the patients and absent in the healthy individuals. No significant difference in transcription levels between the mutations and wild type was observed. Functional analysis revealed that the truncated variants p. A1115Rfs*14 and p. Glu1478Ter exhibited reduced molecular weight and potential functional impairment due to protein retention. The mutations p. A1115Rfs*14 and p. Glu1478Ter in GLI3 may account for sub-PHS and PAP in the two patients, respectively. This finding expands the mutation and phenotype spectrum associated with GLI3, providing valuable insights for the clinical diagnosis of polysyndactyly.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC94 artigos no totalmostrando 66

2025

C-Terminal End of Gli3 Is Critical for Functional Protein Synthesis and Gli3-Dependent Anatomical Development.

Development, growth &amp; differentiation
2025

Shortened and Hypomineralized Bones, Renal Agenesis, and a Heart Defect: Prenatal Diagnosis of a GLI3 Variant.

Prenatal diagnosis
2025

The molecular characterization of seven novel GLI family zinc finger 3 (GLI3) variants in Chinese families with limb malformations.

Frontiers in genetics
2025

New Pathogenic Variant in the GLI3 Gene in the First Colombian Patient Associated With Pallister-Hall Syndrome: A Clinical Report.

Molecular genetics &amp; genomic medicine
2025

Disconnection of Hypothalamic Hamartoma Through Trans-Sylvian Route in a Patient With Pallister-Hall Syndrome: 2-Dimensional Operative Video.

Operative neurosurgery (Hagerstown, Md.)
2025

Two Nonsense GLI3 Variants Are Identified in Two Chinese Families With Polydactyly.

Molecular genetics &amp; genomic medicine
2025

Complete loss of IFT27 function leads to a phenotypic spectrum of fetal lethal ciliopathy associated with altered ciliogenesis.

European journal of human genetics : EJHG
2024

Subglottic stenosis associated with Pallister-Hall syndrome.

Pediatrics international : official journal of the Japan Pediatric Society
2024

Gyratory Seizures in Hypothalamic Hamartoma.

Journal of epilepsy research
2024

Solitary kidney in a patient with Pallister-Hall syndrome.

Kidney international
2024

A novel GLI3 frameshift mutation in a Chinese pedigree with polydactyly: A case report.

Heliyon
2023

Hedgehog-GLI mediated control of renal formation and malformation.

Frontiers in nephrology
2023

Clinical and molecular heterogeneity of syndromic hypothalamic hamartoma.

American journal of medical genetics. Part A
2023

Advances in hypothalamic hamartoma research over the past 30 years (1992-2021): a bibliometric analysis.

Frontiers in neurology
2023

Bardet-Biedl Syndrome Presenting With Bifid Epiglottis: A Case Report and Review of Literature.

Cureus
2023

Mosaic variants detectable in blood extend the clinicogenetic spectrum of GLI3-related hypothalamic hamartoma.

Genetics in medicine open
2025

Prenatal diagnosis of Pallister-Hall syndrome: ultrasound, magnetic resonance imaging, and three-dimensional reconstructions of phenotypical findings.

Journal of ultrasound
2023

Potential benefit of rapid genetic testing for Pallister-Hall syndrome.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
2023

[Analysis of variant of GLI3 gene in a child featuring autosomal dominant Pallister-Hall syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2022

Pallister-Hall syndrome, GLI3, and kidney malformation.

American journal of medical genetics. Part C, Seminars in medical genetics
2022

Pallister-Hall syndrome diagnosed in a young man after an acute adrenal crisis.

Clinical case reports
2022

Neuroimaging appearance of hypothalamic hamartomas in monozygotic twins with Pallister-Hall syndrome: case report and review of the literature.

BMC neurology
2022

Presumptive Diagnosis of Pallister-Hall Syndrome Using Magnetic Resonance Imaging.

Cureus
2022

Giant cystic hypothalamic hamartoma in an infant associated with persistent syndrome of inappropriate antidiuretic hormone secretion.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2022

Bi-allelic SMO variants in hypothalamic hamartoma: a recessive cause of Pallister-Hall syndrome.

European journal of human genetics : EJHG
2021

Case Report: Whole-Exome Sequencing of Hypothalamic Hamartoma From an Infant With Pallister-Hall Syndrome Revealed Novel de novo Mutation in the GLI3.

Frontiers in surgery
2021

GLI3 variants causing isolated polysyndactyly are not restricted to the protein's C-terminal third.

Clinical genetics
2021

Homozygous GLI3 variants observed in three unrelated patients presenting with syndromic polydactyly.

American journal of medical genetics. Part A
2020

Disruption of a hedgehog-foxf1-rspo2 signaling axis leads to tracheomalacia and a loss of sox9+ tracheal chondrocytes.

Disease models &amp; mechanisms
2020

From Skin to Kidneys: Cutaneous Clues of Renal Disease in Children.

Dermatology practical &amp; conceptual
2021

Variant type and position predict two distinct limb phenotypes in patients with GLI3-mediated polydactyly syndromes.

Journal of medical genetics
2020

Pre- and postnatal MR imaging of an asymptomatic giant hypothalamic hamartoma.

Radiology case reports
2020

A GLI3 variant leading to polydactyly in heterozygotes and Pallister-Hall-like syndrome in a homozygote.

Clinical genetics
2021

Pallister Hall Syndrome: Laryngeal Anomalies and Failure to Thrive.

Ear, nose, &amp; throat journal
2019

Teaching NeuroImages: Hypothalamic hamartoma and polydactyly: Think Pallister-Hall syndrome.

Neurology
2020

Genetic factors in isolated and syndromic laryngeal cleft.

Paediatric respiratory reviews
2020

Concurrent Hirschsprung's disease and anorectal malformation: a systematic review.

Pediatric surgery international
2019

Critical association of Pallister-Hall syndrome and congenital heart disease.

Pediatrics international : official journal of the Japan Pediatric Society
2019

Pallister-Hall Syndrome Presenting in Adolescence.

Case reports in genetics
2020

Lineage-specific roles of hedgehog-GLI signaling during mammalian kidney development.

Pediatric nephrology (Berlin, Germany)
2019

Pallister-Hall syndrome in a 2-years-old girl.

Pediatric endocrinology, diabetes, and metabolism
2019

A Novel Frameshift Mutation of GLI3 Causes Isolated Postaxial Polydactyly.

Annals of plastic surgery
2019

Pallister-Killian Syndrome: The Diagnosis is in the Detail.

Klinische Padiatrie
2019

A familial syndrome of hypothalamic hamartomas, polydactyly, and SMO mutations: a clinical report of 2 cases.

Journal of neurosurgery. Pediatrics
2018

Pallister-Hall syndrome with orofacial narrowing and tethered cord: a case report.

Journal of medical case reports
2018

A delayed diagnosis of Pallister-Hall syndrome in an adult male following the incidental detection of a hypothalamic hamartoma.

Human genome variation
2018

Bifid epiglottis, high-arched palate, and mental disorder in a patient with Pallister-Hall syndrome.

Indian journal of anaesthesia
2018

Loss of function IFT27 variants associated with an unclassified lethal fetal ciliopathy with renal agenesis.

American journal of medical genetics. Part A
2018

Difficult airway associated with bifid glottis and coexistent subglottic stenosis in a patient with Pallister-Hall syndrome: a case report.

JA clinical reports
2018

Novel GLI3 variant causing overlapped Greig cephalopolysyndactyly syndrome (GCPS) and Pallister-Hall syndrome (PHS) phenotype with agenesis of gallbladder and pancreas.

Diagnostic pathology
2017

Human Malformation Syndromes of Defective GLI: Opposite Phenotypes of 2q14.2 (GLI2) and 7p14.2 (GLI3) Microdeletions and a GLIA/R Balance Model.

Cytogenetic and genome research
2017

Familial Pallister-Hall in adulthood.

Neuro endocrinology letters
2017

Compound heterozygous alterations in intraflagellar transport protein CLUAP1 in a child with a novel Joubert and oral-facial-digital overlap syndrome.

Cold Spring Harbor molecular case studies
2018

Congenital Hypothalamic "Hamartoblastoma" Versus "Hamartoma": Suggestions for Neuropathologic Terminology Emanating From a Mid-gestational Autopsy Case of Pallister-Hall Syndrome.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2017

GLI3-related polydactyly: a review.

Clinical genetics
2016

Control of Hedgehog Signalling by the Cilia-Regulated Proteasome.

Journal of developmental biology
2016

Bifid epiglottis in a patient with Pallister-Hall syndrome.

Canadian journal of anaesthesia = Journal canadien d'anesthesie
2016

Somatic mutations in GLI3 and OFD1 involved in sonic hedgehog signaling cause hypothalamic hamartoma.

Annals of clinical and translational neurology
2016

Hypothalamic hamartoma with neurofibrillary tangles.

Neuropathology : official journal of the Japanese Society of Neuropathology
2016

Congenital Bilateral Saccular Cysts and Bifid Epiglottis: Presentation and Management.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2016

The early history of Pallister-Hall syndrome-Buried treasure of a sort.

Gene
2016

TWO DIFFERENT MUTATIONS OF GL13 GENE IN TWO DIFFERENT SYNDROMES.

Genetic counseling (Geneva, Switzerland)
2016

Urogenital development in Pallister-Hall syndrome is disrupted in a cell-lineage-specific manner by constitutive expression of GLI3 repressor.

Human molecular genetics
2015

[Polydactyly, holoprosencephaly, cleft lip and cleft palate are not always what they seem: Case report].

Archivos argentinos de pediatria
2015

Teaching neuroImages: short stature, imperforate anus, and polydactyly: When is a hypothalamic mass an incidentaloma?

Neurology
2015

Total colonic aganglionosis and imperforate anus in a severely affected infant with Pallister-Hall syndrome.

American journal of medical genetics. Part A
Ver todos os 94 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Pallister-Hall syndrome.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Pallister-Hall syndrome e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

A condição é causada principalmente por mutações genéticas no gene GLI3, com herança autossômica dominante. O gene SMO também está catalogado entre os genes associados a este quadro.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

7 publicações do grafo RarasNet (PubMed) · 7 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:672
    Orphanet
  2. GARD:7305
    GARD (NIH)
  3. Q3085434
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Pallister-Hall syndrome. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/pallister-hall-syndrome

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Pallister-Hall syndrome

ORPHA:672 · MONDO:0007804
🇧🇷 Brasil SUS
SIGTAP
5 procedimentos
Geral
Prevalência
<1 / 1 000 000
Casos
100 casos conhecidos
Herança
Autosomal dominant, Not applicable
CID-10
Q87.8 · Outras síndromes com malformações congênitas especificadas, não classificadas em outra parte
CID-11
Início
Antenatal, Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0265220
EuropePMC
Wikidata
Papers 10a
Evidência
🥉 Relato de caso

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Genética mendeliana
fonte: OMIM
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Rara